Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Nano Dimension Ltd.
13D/A
Amendment 18
NNDM · 63008G203
|
8.1% |
7/20/2026
Event 7/17/2026
|
|||
| Murchinson Ltd. | 8.1% | ||||
| Nomis Bay Ltd. | 2.4% | ||||
| BPY Ltd. | 1.6% | ||||
| EOM Management Ltd. | 4.1% | ||||
| James Keyes | 4.1% | ||||
| Jason Jagessar | 4.1% | ||||
| Chaja Carlebach | 4.1% | ||||
| Clarendon Hugh Masters | 4.1% | ||||
| Marc J. Bistricer | 8.1% | ||||
|
Valion Bio, Inc.
13G
VBIO · 888705308
|
10.0% |
7/17/2026
Event 6/8/2026
|
|||
| Murchinson Ltd. | 10.0% | ||||
| Marc Bistricer | 10.0% | ||||
| BPY Ltd. | 10.0% | ||||
| Nomis Bay Ltd. | 10.0% | ||||
| Nomis Bay Opportunity Ltd. | 10.0% | ||||
| EOM Management Ltd. | 10.0% | ||||
| James Keyes | 10.0% | ||||
| Jason Jagessar | 10.0% | ||||
| Chaja Carlebach | 10.0% | ||||
|
Nano Dimension Ltd.
13D/A
Amendment 17
NNDM · 63008G203
|
9.6% |
6/23/2026
Event 6/22/2026
|
|||
| Murchinson Ltd. | 9.6% | ||||
| Nomis Bay Ltd. | 2.9% | ||||
| BPY Ltd. | 1.9% | ||||
| EOM Management Ltd. | 4.8% | ||||
| James Keyes | 4.8% | ||||
| Jason Jagessar | 4.8% | ||||
| Chaja Carlebach | 4.8% | ||||
| Clarendon Hugh Masters | 4.8% | ||||
| Marc J. Bistricer | 9.6% | ||||
|
Nano Dimension Ltd.
13D/A
Amendment 16
NNDM · 63008G203
|
7.4% |
5/21/2026
Event 5/19/2026
|
|||
| Murchinson Ltd. | 7.4% | ||||
| Nomis Bay Ltd. | 2.2% | ||||
| BPY Ltd. | 1.5% | ||||
| EOM Management Ltd. | 3.7% | ||||
| James Keyes | 3.7% | ||||
| Jason Jagessar | 3.7% | ||||
| Chaja Carlebach | 3.7% | ||||
| Marc J. Bistricer | 7.4% | ||||
|
Pelthos Therapeutics Inc.
13G
PTHS · 171126204
|
9.1% |
11/14/2025
Event 9/30/2025
|
|||
| Murchinson Ltd. | 9.1% | ||||
| Marc Bistricer | 9.1% | ||||